Introduction
. Moreover, the activation of this chimera is energy-dependent, suggesting a requirement Interactions between integrin cell adhesion receptors for cellular signaling pathways in activating endogenous and their extracellular ligands are central to cell migra-␣ 5 ␤ 1 . The monoclonal antibody PAC1 is specific for the tion, growth, and survival (Hynes, 1992; Schwartz et al., high affinity conformation of ␣ IIb ␤ 3 , mimicking the binding 1995). A characteristic feature of certain integrins is their characteristics of the natural ligand, fibrinogen (Shattil ability to modulate their affinity for extracellular ligands et al., 1985) . Thus, the combined properties of the active in response to intracellular signals, a process termed ␣ IIb␤3 chimeras and the activation-dependent ligand, "activation" or "inside-out signaling" (reviewed by Wil-PAC1, permit the use of the extracellular domain of ␣ IIb␤3 liams et al., 1994) . Integrin activation is energy-depenas a reporter of cytoplasmic signaling events involved dent and cell type-specific, requiring both the ␣ and in integrin activation. ␤ subunit cytoplasmic domains  To identify suppressors of integrin activation, we Hughes et al., 1996) . screened a collection of cDNAs for their ability to supSeveral observations suggest that there are cytopress PAC1 binding to a CHO cell line expressing an plasmic signaling pathways that suppress integrin actiactive ␣ IIb ␤ 3 chimera. We found that the expression of vation. For example, integrin activation in T cells is often activated variants of the small GTP-binding protein, transient, even with continued stimulation (Dustin and H-Ras, and its kinase effector, Raf-1, blocks integrin Springer, 1989; Shimizu et al., 1990) . Cell migration reactivation. Furthermore, this suppressive activity correquires coordinated adhesion and de-adhesion events, lates with activation of the ERK MAP kinase pathway and the "freezing" of integrins in an activated state alters (extracellular signal-regulated protein kinase [ERK] micell migration (Kuijpers et al., 1993) . Platelet-derived togen-activated protein [MAP] kinase pathway) and growth factor inhibits platelet aggregation, suggesting does not require protein synthesis or mRNA tranthat activation of a tyrosine kinase receptor impairs the scription. function of integrin ␣ IIb␤3 (Vassbotn et al., 1994) . During mitosis, cells become rounded and appear to lose adhesion. Phosphorylation of a conserved serine residue in Results the ␤ 1 cytoplasmic domain may be responsible for this loss of integrin function in mitotic cells (Hynes, 1992) .
H-Ras and Activated Raf-1 Kinase Suppress Integrin Activation Signaling events initiated by the occupancy of one integrin can suppress functions associated with other inteUsing two-color flow cytometry, we screened a collection of 102 cDNAs for suppressors of integrin activation. grins (Blystone et al., 1995; Diaz-Gonzalez et al., 1996) . . Suppression of Integrin Activation in Transient Transfecalone or Tac-␣5 plus H-Ras(G12V). After 48 hr, cells were harvested tions and stained for Tac expression (ordinate) and PAC1 binding (ab-CHO cells were cotransfected with 2 g of cDNA encoding ␣ IIb ␣ 6A scissa). In the Ras(G12V)-transfected cells there is a leftward shift and 2 g of cDNA encoding ␤ 3 ␤ 1 . They were also simultaneously of the dot plot in the upper but not lower quadrants, representing cotransfected with 1, 2, or 4 g of a cDNA encoding R-Ras(G38V), a reduction in PAC1 binding (top left). This shift is reversed by the Raf-BXB, or H-Ras(G12V). After 48 hr, cells were harvested and addition of an activating monoclonal antibody, anti-LIBS6, estabanalyzed for PAC1 binding. The reduction in specific PAC1 binding lishing that it is due to "deactivation" of the integrin by the was used to calculate the percentage inhibition relative to the transfected Ras(G12V) cDNA (top right). In the empty vector transpcDNA3 control. Depicted is the mean percentage inhibition relative fection, there was no suppression of PAC1 binding in the Tac-␣ 5 - to empty vector Ϯ SE of three independent determinations. expressing cells (bottom left and bottom right).
These cDNAs encoded cytoskeletal proteins relevant to 2), Cdc42(Q61L), RhoA(Q63L), and Rac-1(Q61L) (data integrin function (e.g., ␣-actinin and vinculin), protein not shown) did not suppress integrin activation. kinases (e.g., focal adhesion kinase [FAK] and protein kinase C isoforms), and small G proteins (e.g., Rac-1, H-Ras Suppresses the Activation of Integrins H-Ras, and R-Ras). The cDNAs were grouped into pools with Distinct Cytoplasmic Domains of six to eight clones and cotransfected into CHO cells To test whether the suppressive effect of activated stably expressing the active chimeric integrin ␣ IIb ␣ 6A ␤ 3 ␤ 1 H-Ras was restricted to the ␤ 1 and ␣ 6A cytoplasmic do-(␣␤-py cells) along with a vector encoding the extracellumains, we transiently transfected CHO cells with differlar domain of the Tac subunit of the interleukin-2 recepent active ␣ IIb␤3 chimeras in the presence or absence of tor (LaFlamme et al., 1992) . After 48 hr, the cells 2 g of H-Ras(G12V) cDNA. We tested chimeras comwere harvested and analyzed by flow cytometry for antiposed of the cytoplasmic domains of ␣ 6A, ␣6B, and ␣5 Tac (to identify transfected cells) and PAC1 (to assess fused to the extracellular and transmembrane domains integrin affinity state) binding. From this screen we isoof ␣ IIb. These ␣IIb subunit chimeras were then coexlated three different cDNAs: those encoding both actipressed with both native ␤ 3 and a ␤ 3 chimera containing vated (G12V) and wild-type forms of the small GTPthe cytoplasmic domain of ␤ 1 . When coexpressed with binding protein H-Ras (Figure 1 ) and an activated variant each chimera, activated H-Ras suppressed PAC1 bindof the serine/threonine kinase Raf-1 (Raf-BXB) (data not ing ( Figure 3 ) by an average of 73% Ϯ 4.2%. Therefore, shown) that suppressed PAC1 binding (Figure 1 ). PAC1 the effects of activated H-Ras are not specific for ␣ 6A binding to the H-Ras-or Raf-BXB-transfected cells and ␤ 1 but also extend to other integrin cytoplasmic could be restored by addition of an "activating" monodomains. clonal antibody, anti-LIBS6 (Figure 1) , showing that Activated H-Ras or Raf-1 could suppress integrin actithere was no reduction in the expression of the recombivation by activating downstream kinases that phosphornant integrin following transfection with H-Ras(G12V) ylate the ␣ 6A or ␤1 cytoplasmic tails. However, we found or Raf-BXB. Also, suppression was cell-autonomous, no detectable phosphorylation of ␣ IIb␣6A␤3␤1 following since only transfected cells showed a reduction in PAC1
Raf-1 activation even though integrin activation was binding (Figure 1 ).
suppressed (data not shown). This observation sugTo exclude the possibility that the observed effect gests that phosphorylation of the integrin cytoplasmic depended on the use of a clonal cell line and the Tac domains is not required for suppression of integrin actimarker, we transiently transfected CHO cells with exvation. However, it is possible that rapid and transient pression vectors for both the chimeric integrin and the phosphorylation occurs below the limits of detection or suppressor molecules. Both Raf-BXB and H-Ras supbefore the earliest time point examined (1 hr). Therepressed integrin activation (Figure 2 ). The effect of actifore, we wished to determine whether the mutation of vated H-Ras was not a general property of small G proteins, because the transfection of R-Ras(G38V) (Figure certain known phosphorylation sites could block H-Ras-part via multiple distinct MAP kinase cascades. Raf-1 is a downstream effector of Ras, leading to the activation of the ERK1/ERK2 MAP kinases (Howe et al., 1992) . Therefore, the suppressive effect of H-Ras and Raf-BXB on integrin activation may be mediated by the activation of one or more of the MAP kinase pathways. To test this hypothesis we examined the effect of MAP kinase phosphatase 1 (MKP-1) (Sun et al., 1993) on suppression mediated by H-Ras(G12V) and Raf-BXB. ␣␤-py cells were transiently transfected with H-Ras(G12V) or Raf-BXB in the presence or absence of MKP-1. Integrin activation ( Figure 4A ) and the activation of ERK2 kinase were then analyzed ( Figure 4B ). MKP-1 reversed the activation of ERK2 by H-Ras(G12V) and Raf-BXB and reduced the inhibition of integrin activation. These results indicate that the suppressive effects of H-Ras (G12V) and Raf-BXB are due to the activation of a MAP kinase pathway. Since MKP-1 can inactivate both ERK and JNK, we pathway . The suppression of intedifferent ␣ subunit cytoplasmic domains, CHO cells were cotransfected with 2 g of cDNA encoding the chimera ␤ 3␤1 and 2 g of grin activation ( Figure 4A ) and the activation of MAP cDNA encoding ␣IIb␣6A, ␣IIb␣6B, or ␣IIb␣5. They were also simultanekinase pathways were analyzed ( Figure 4B ing to ERK1/ERK2 activation, rather than that leading to JNK activation, is involved in the suppression of integrin activation by Raf-BXB and H-Ras(G12V). mediated suppression. We transiently transfected CHO We wished to determine whether the activation of cells with active variants containing mutations at known endogenous Ras could suppress integrin activation. The phosphorylation sites. The chimera ␤ 3 ␤ 1 (S790M) contyrosine kinase Src is known to activate the ERK MAP tains a methionine substituted for a serine residue phoskinase pathway in a Ras-dependent manner (Brown and phorylated in mitotic cells (Hynes, 1992) . H-Ras(G12V) Cooper, 1996) . Therefore, we examined the ability of suppressed PAC1 binding to ␣IIb␣6A␤3␤1(S790M) (Figure two activated forms of Src, Src(E378G) and v-Src, to 3). Therefore, the ability of H-Ras(G12V) to suppress suppress integrin activation in ␣␤-py cells. We found activation of this mutant is not the result of phosphorylathat both Src(E378G) and v-Src suppressed PAC1 bindtion of S790. The ␤ 3 cytoplasmic domain contains two ing ( Figure 4C ). This suppression was dependent on tyrosine residues as part of a conserved NPXY and a the activation of the endogenous Ras-dependent MAP more distal NXXY motif. One or both of these tyrosine kinase pathway, as cotransfection of dominant negative residues are phosphorylated during thrombin-induced H-Ras(S17N) ( Figure 4C ) or MKP-1 (data not shown) platelet aggregation (Law et al., 1996) . We substituted markedly reduced the suppressive effect of both forms both of these tyrosines with phenylalanine in ␤ 3 (Y747F, of activated Src. Thus, the activation of an endogenous Y759F), eliminating the possible phosphorylation of Ras can induce suppression of integrin activation. these residues. H-Ras(G12V) suppressed PAC1 binding to ␣IIb␣6A␤3(Y747F, Y759F) ( Figure 3) . Therefore, the ability of activated H-Ras to suppress the activation of this Suppression of Integrin Activation Occurs without Transcription or Protein Synthesis mutant was not mediated by the phosphorylation of tyrosine residues on the ␤3 cytoplasmic domain. These Activation of the ERK MAP kinase pathway induces immediate-early gene expression (Marshall, 1995) . Thus, data indicate that Ras-and Raf-mediated suppression of integrin activation is not due to the phosphorylation we wished to determine whether the suppression of integrin activation required the transcription and de of the integrin cytoplasmic domains. novo synthesis of a suppressive factor. To test this possibility, we used Raf-ER cells that express the estrogenIntegrin Suppression Correlates with Activation of a MAP Kinase dependent Raf-1, Raf-1.ER. Upon addition of estradiol, Raf-1.ER is rapidly activated in the absence of protein Ras plays a central role in the transduction of signals from growth factor and G protein-coupled receptors, in synthesis (Samuels et al., 1993 ).
In the absence of estradiol, the Raf-ER cells bound assembled an extensive fibronectin matrix that was inhibited by the function-blocking anti-␣5 antibody PB1 PAC1 with high affinity ( Figure 5A ). However, following the addition of estradiol, PAC1 binding was reduced ( Figure 6 ). Therefore, in the presence of lamifiban, endogenous ␣ 5 ␤ 1 mediated fibronectin matrix assembly. ( Figure 5A ) but was restored by addition of the activating antibody anti-LIBS6. There was no reduction in the Addition of estradiol almost totally blocked fibronectin matrix assembly by these cells, whereas estradiol had abundance of ␣ IIb ␣ 6A ␤ 3 ␤ 1 following the addition of estradiol, as determined by simultaneous anti-␣ IIb ␤ 3 staining no effect on CHO cells lacking Raf-1.ER. To test whether the inhibition of fibronectin matrix assembly was due to ( Figure 5A ). In addition, PAC1 binding in the presence of anti-LIBS6 was the same whether estradiol was added an estradiol-induced reduction in ␣ 5 ␤ 1 expression in Raf-ER cells, we measured the number of ␣ 5 ␤ 1 receptors in (fluorescence intensity ϭ 20 Ϯ 5.1 units) or not (fluorescence intensity ϭ 18 Ϯ 5 units), further confirming that the presence and absence of estrogen with radiolabeled PB1 antibody. We found that there were 1.8 ϫ 10 5 Ϯ estradiol did not affect recombinant ␣IIb␣6A␤3␤1 expression. The addition of estradiol in the absence of Raf-2.2 ϫ 10 4 molecules/cell in the presence of estradiol compared to 1.8 ϫ 10 5 Ϯ 1.3 ϫ 10 4 molecules/cell in the 1.ER had no effect on PAC1 binding to ␣IIb␣6A␤3␤1 ( Figure  5A ). These data indicate that the suppression of PAC1 absence of estradiol. Therefore, Raf-1 activation suppresses the capacity of integrin ␣5␤1 to mediate fibronecbinding to Raf-ER cells by estradiol is due to Raf-1 kinase activation.
tin matrix assembly without affecting the integrin's abundance. We next examined the effect of Raf-1 activation in the presence of cycloheximide or actinomycin D, inhibitors
We next examined the effect of activated Raf-1 on the morphology of Raf-ER cells plated on fibronectin of protein synthesis and mRNA transcription, respectively. In the absence of estradiol, both cycloheximide and fibrinogen. In the absence of estradiol, Raf-ER cells adhered and spread normally on both fibrinogen and (20 g/ml) and actinomycin D (2 g/ml) had little effect on PAC1 binding to Raf-ER cells ( Figure 5B ). In the fibronectin. Activation of Raf-1 following the addition of estradiol to the culture medium resulted in a profound presence of both estradiol and either cycloheximide (20 g/ml) or actinomycin D (2 g/ml), PAC1 binding was effect on cell shape ( Figures 6E and 6F ). The cells lost their spread phenotype and adopted a more rounded nearly completely inhibited. Total protein synthesis was inhibited by 98% in the cells treated with 20 g/ml cycloshape ( Figure 6F ). There were no changes in the morphology of the cells lacking activated Raf-ER. heximide either in the presence or absence of estradiol, as assessed by incorporation of [
35 S]methionine into trichloroacetic acid-insoluble protein. Thus, the supDiscussion pressive effect of activated Raf-1 does not require substantial mRNA transcription or protein synthesis.
We report the identification and characterization of a We used the Raf-ER cells to determine the time course signal transduction pathway that leads to the suppresof suppression following the activation of Raf-1. Rafsion of integrin activation. The major findings are as ER cells were treated with cycloheximide to block upfollows. First, this suppression pathway involves the regulation of MKP-1 (Sun et al., 1993) . PAC1 binding small GTP-binding protein H-Ras and its downstream and ERK2 kinase activity were then assayed in parallel effector kinase Raf-1. Second, activated H-Ras supat hourly intervals from 0 to 4 hr after the addition of presses the activation of integrins with multiple ␣ and estradiol. After 1 hr, ERK2 activity was near maximal, ␤ subunit cytoplasmic domains. The suppressive effect as expected (Samuels et al., 1993) . However, suppresis not associated with integrin phosphorylation, nor is sion of PAC1 binding was delayed ( Figure 5C ). After 2 it reversed by mutations that eliminate certain known hr, integrin activation was suppressed by 60%, with phosphorylation sites in the ␤3 or ␤1 cytoplasmic domaximal suppression reached after 3 hr ( Figure 5C ). The mains. Third, the suppression of integrin activation by addition of cycloheximide alone to Raf-ER cells had no H-Ras(G12V) and Raf-BXB correlates with activation of effect on PAC1 binding to ␣ IIb ␣ 6A ␤ 3 ␤ 1 (data not shown).
the ERK but not the JNK MAP kinase pathway. Fourth, the suppressive effect of Raf-1 does not require mRNA Activation of Raf-1 Suppresses Fibronectin Matrix transcription or protein synthesis. These data identify Assembly and Changes Integrin-Dependent integrin affinity state as a novel, transcription-indepenCell Morphology dent target of Ras-initiated MAP kinase pathways. They To determine whether this suppression pathway could also provide a cogent explanation for the alteration of inhibit other integrin-dependent functions, we examined certain integrin-dependent functions in many transthe effect of activated Raf-1 on fibronectin matrix asformed cells. sembly and cell morphology. In these experiments, we
Expression of activated variants of the small GTPused the Raf-ER cells in which Raf-1 kinase activity is binding protein H-Ras and the serine/threonine kinase controlled by the presence of exogenous estradiol.
Raf-1 blocked integrin activation. This result was obWe examined the effect of activated Raf-1 on ␣ 5 ␤ 1 -served with a series of chimeric integrins in which the mediated fibronectin matrix assembly, a process requirextracellular and transmembrane domains of ␣ IIb ␤ 3 were ing an activated integrin (Wu et. al., 1995) . Because the joined to the cytoplasmic domains of ␣ 6A , ␣ 6B , and ␣ 5 Raf-ER cells could use the recombinant ␣ IIb ␣ 6A ␤ 3 ␤ 1 to and ␤ 1 . Each of these ␣ subunit cytoplasmic domains assemble a matrix, we added saturating quantities of has a highly distinct sequence. In contrast, both the an ␣IIb␤3 specific inhibitor, lamifiban, to all samples to ␤ 1 and ␤ 3 tails share homologous sequence motifs in ensure that matrix assembly was mediated only by endogenous ␣ 5 ␤ 1 . In the absence of estradiol, Raf-ER cells common with other ␤ subunit cytoplasmic domains. This raises the possibility that the suppression pathway is acting in a ␤ subunit-dependent manner or, alternatively, that it is capable of acting via multiple ␣ subunit cytoplasmic domains. Earlier reports suggested that the tyrosine phosphorylation of either ␤1 or ␤3 subunit cytoplasmic domains can influence integrin function and localization (Johansson et al., 1994; Law et al., 1996) . However, activated H-Ras was able to suppress the activation of the double mutant ␣ IIb ␣ 6A ␤ 3 (Y747F, Y759F), demonstrating that suppression is not the result of the phosphorylation of tyrosine residues in the ␤3 cytoplasmic domain. In addition, activated H-Ras was able to suppress the activation of ␣ IIb ␣ 6A ␤ 3 ␤ 1 (S790M). The serine residue substituted with methionine in ␤ 3 ␤ 1 (S790M) corresponds to the serine phosphorylated in mitotic cells (Hynes, 1992) . This result shows that this effect is distinct from the reported effects of S790 phosphorylation and represents a second potential mechanism for regulation of integrin function in concert with the cell cycle.
The inhibition of integrin activation by activated H-Ras and Raf-1 correlated with activation of the ERK but not the JNK MAP kinase pathway. Ras plays a pivotal role in the transduction of signaling events initiated by both tyrosine kinase growth factor receptors and G proteincoupled receptors. Activated Ras can interact with multiple downstream effectors, controlling both gene expression and the organization of the actin cytoskeleton (reviewed by Hall, 1992) . Given that the other Ras family members, N-Ras and K-Ras, have downstream effectors similar to those of H-Ras, these Ras family members would also be expected to suppress integrin activation. Indeed, an activated variant of K-Ras(C12V) suppresses PAC1 binding to ␣␤-py cells (Ginsberg and Forsyth, unpublished data). Raf-1 is a downstream effector of H-Ras that induces the activation of the ERK1/ERK2 MAP kinases (Howe et al., 1992) . Because Raf-1 had a suppressive effect similar to that of activated H-Ras, integrin suppression may be mediated by the activation of one or more of the MAP kinase pathways. Moreover, MKP-1, a MAP kinase phosphatase, partially reversed the suppressive effect of both activated H-Ras and Raf-1. In the same experiment, MKP-1 completely reversed activation of recombinant ERK2 induced by activated Raf failed to activate ERK2 but activated JNK1. Immunoblotting revealed or vectors bearing inserts encoding Cdc42(Q61L), Raf-BXB, or an equivalent amount of ERK2 and JNK1 in each of the kinase Ras(G12V). In separate transfections, 2 g of Raf-BXB or Ras(G12V) reactions (data not shown). (Bottom) Immunoblots with the anti-HA cDNA were cotransfected with 6 g of a plasmid encoding MKP-1. antibody 12CA5. There was a comparable expression of either HAAfter 48 hr, PAC1 binding was determined by flow cytometry. Detagged ERK2 or JNK1 in all transfections. The Ras(G12V) construct picted is the mean percentage inhibition relative to empty vector Ϯ bore an HA-tag and was detected as the the lower band in lanes SE of three independent determinations. transfected with that construct. Note the similar expression of re-(B) ␣␤-py cells were cotransfected with 2 g of an expression vector combinant activated Ras in both the control and MKP-1-cotransencoding HA-tagged ERK2 or HA-tagged JNK1. The cells were also fected cells. cotransfected with 2 g of expression vector (None) or vectors (C) ␣␤-py cells were transfected with 4 g of an expression vector containing inserts encoding Cdc42(Q61L), Raf-BXB, or Ras(G12V).
encoding either v-Src or Src(E378G). In separate transfections, 4 In separate transfections, 2 g of expression vectors encoding either g of expression vectors encoding either Src(E378G) or v-Src were Raf-BXB or Ras(G12V) were simultaneously cotransfected with 6 simultaneously cotransfected with 1 g of a plasmid encoding domig of a plasmid encoding MKP-1. The transfected kinases were nant negative Ras(S17N). After 48 hr, integrin activation was deterimmunoprecipitated with anti-HA antibody 12CA5. ERK2 activity mined by PAC1 binding. Depicted is the mean percentage inhibition was measured by phosphorylation of myelin basic protein by an inrelative to the empty vector control Ϯ SE of three independent gel kinase assay, and JNK-1 activity was measured by the phosdeterminations. and Ras. This difference suggests the possibility of addimediated by a MAP kinase-dependent integrin suppression pathway. MKP-1 can dephosphorylate and theretional MAP kinase-independent pathway(s) that suppress integrin activation. Alternatively, endogenous fore inactivate ERK, JNK, and p38 kinases (Chu et al., 1996) . However, we found that the suppression of inte-ERK's or other MAP kinases may have been only partially inactivated by the transfected MKP-1. Nevertheless, it grin activation correlated with activation of the ERK but not the JNK MAP kinase pathway. is clear that the effect of activated Ras and Raf was Raf-ER cells were cultured in medium supplemented with human fibronectin (150 g/ml) and the ␣IIb␤3-specific inhibitor lamifiban (1 M). Cells cultured in the absence of estradiol (A) assembled an extensive fibronectin matrix. In contrast, fibronectin matrix assembly was reduced in cells grown in the presence of estradiol (B). In the absence of estradiol, fibronectin matrix assembly was completely inhibited in Raf-ER cells following the addition of the anti-␣ 5 antibody PB1 (C). Estradiol had no effect in cells lacking Raf-1.ER (D). To determine the effect of activated Raf-1 on the adhesive phenotype, Raf-ER cells were plated on fibrinogen-coated coverslips (5 g/ ml) and cultured in the absence (E) or presence (F) of estradiol for 24 hr. Cells cultured in the absence of estradiol (E) exhibited a normal spread morphology. In contrast, cells plated on fibrinogen in the presence of estradiol were less well spread and displayed a more rounded phenotype (F). Identical results were obtained for cells plated on fibronectin (not shown).
Activated variants of the tyrosine kinase Src could induced inhibition. These two findings suggest that suppression is the result of downstream signaling events also suppress integrin activation via a Ras-dependent MAP kinase pathway. These results establish that the initiated by H-Ras. Thus, H-Ras-mediated suppression does not appear to be the consequence of simple comactivation of endogenous Ras can also inhibit integrin activation. In addition, the fact that overexpressed wildpetition between H-Ras and R-Ras for common effectors. It would be of interest to determine whether type H-Ras also inhibited PAC1 binding establishes that the suppressive effect of H-Ras(G12V) is not due to its R-Ras "activation" of integrins is the result of competition with Ras for its effectors. ability to interact with a downstream effector unique to the activated variant. Thus, transformation initiated by Using a conditionally activated Raf-1, we found that the suppressive effect of activated Raf-1 was largely oncogenes upstream of Ras can also engage this integrin suppression pathway.
independent of de novo transcription and protein synthesis. The conditional Raf-1 was directly activated by Zhang et al. (1996) reported that R-Ras, a Ras-related small G protein, could "activate" integrins. R-Ras and the addition of exogenous estradiol, and this led to the suppression of integrin activation. In the presence of H-Ras have similar effector binding domains and bind many of the same effectors, including Raf and Ral-GDS inhibitors of mRNA transcription and protein synthesis, the suppressive effect of Raf-1 was maintained. Thus, (Urano et al., 1996) . However, R-Ras and H-Ras have different morphological effects on cells (Cox et al., 1994) , Raf-1-mediated integrin suppression was independent of protein synthesis. The estrogen-dependent Raf-1 alpossibly because R-Ras may not activate some of the Ras effectors to which it binds. Thus, R-Ras could block lowed us to determine the time interval between the activation of Raf-1 and the loss of PAC1 binding. By the suppressive effect of H-Ras by competition for common effectors. Alternatively, activated H-Ras could act monitoring both ERK2 kinase activity and integrin activation we found that maximal suppression was not as a dominant negative inhibitor with respect to the specific effectors of R-Ras involved in integrin activareached until after 3 hr after Raf-1 activation. In contrast, ERK2 kinase activity was maximal 1 hr after addition of tion. However, Raf-1, a downstream effector of H-Ras, induced suppression of integrin activation. Furthermore, estradiol. Therefore, there appears to be a lag period of at least 2 hr between the activation of the ERK MAP a MAP kinase phosphatase, MKP-1, reversed H-Ras-kinase pathway and the suppression of PAC1 binding.
inhibition could be the direct result of the activation of a MAP kinase-dependent integrin suppression pathway. This assay measures the time interval between Raf-1 activation and the loss of PAC1 binding to a previously Deregulation of the MAP kinase pathway is often associated with oncogenic transformation, suggesting that activated integrin. One explanation for this lag period is that the activation of the MAP kinase pathway may initimalignant transformation could produce a sustained activation of this integrin suppression pathway. Unreguate the disassembly of an integrin "activation" complex. Alternatively, it is possible that integrins on the cell surlated action of an integrin suppression pathway may help to explain some of the characteristics of the transface cycle between active and inactive states and that the integrin suppression pathway may act by supformed phenotype, such as the loss of fibronectin matrix assembly and altered cell migration and morphology. pressing only the activation step. Thus, the lag period could be due to the time required for the previously Indeed, we show that a conditionally active Raf-1 is able to inhibit integrin ␣5␤1-mediated fibronectin matrix active receptors to lose the capacity to bind PAC1.
Our results indicate that integrin suppression is mediassembly and induce changes in integrin-dependent cell morphology. Moreover, it is likely that a cytoplasmic ated by transcription-independent signaling through a MAP kinase pathway. There are examples of cytosolic substrate(s) of a MAP kinase are involved in suppression, since de novo protein synthesis is not required. signaling events downstream of MAP kinases. For example, MAP kinases can phosphorylate and thus actiThus, these data point to a novel Ras-initiated effector pathway that is responsible for some of the phenotypic vate cytoplasmic phospholipase A2 in vitro (Lin et al., 1993) and MAP kinase can phosphorylate the gap juncalterations frequently found in transformed cells. tion protein connexin 43 (Kanemitsu and Lau, 1993) .
Experimental Procedures
However, the biological significance of these events has yet to be determined. We found that a cellular function, (Schlaepfer et al., 1994; Marshall, 1995) . In both events, specific peptidomimetic inhibitors Ro44-9883 (lamifiban) and Ro43of inhibitors of protein synthesis and transcription on the supexamined by phase-contrast microscopy. Photographs were then taken on Tmax 400 film. pressive effect of activated Raf-1, cycloheximide (20 g/ml) or actinomycin D (2 g/ml) was added to Raf-ER cells for 24 hr in the presence and absence of estradiol (13 M). The cells were then Acknowledgments harvested and assayed for PAC1 binding. In experiments measuring the time course of integrin suppression, cycloheximide (20 g/ml) Correspondence should be addressed to M. H. G. (e-mail: ginsberg @scripps.edu). We thank our colleagues for generously providing was added to the Raf-ER cells in the presence of estradiol (13 M) for 4 hr. Aliquots of cells were then harvested at hourly intervals the reagents acknowledged in Experimental Procedures. We thank Dr. Joe Ramos for critical review of the manuscript. P. E. H. is a and assayed for both PAC1 binding and ERK2 kinase activity. As a control, PAC1 binding and ERK2 activity were assayed in Raf-ER postdoctoral fellow of the American Heart Association. M. W. R was supported by a postdoctoral training grant from the National cells incubated in the presence of 20 g/ml cycloheximide for 4 hr.
To (1992) . Serum, TPA, and fection the cells were harvested and lysed as described (Renshaw ras induced expression from AP-1/Ets-driven promoters requires et al., 1996). HA-ERK2 activity was assayed either by an in-gel kinase Raf-1 kinase. Genes Dev. 6, 545-555. assay (Renshaw et al., 1996) or by an immune-complex kinase assay Burridge, K., Fath, K., Kelly, T., Nuckolls, G., and Turner, C. (1988) . with myelin basic protein as a substrate. In experiments monitoring Focal adhesions: transmembrane junctions between the extracelluthe activity of endogenous ERK2, the ERK2 was immunoprecipated lar matrix and the cytoskeleton. Annu. Rev. Cell Biol. 4, 487-525. with polyclonal anti-ERK2 (Santa Cruz). ERK2 kinase activity was Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani, then assayed by an immune-complex kinase assay with myelin basic A., Kapeller, R., and Soltoff, S. (1991) . Oncogenes and signal transprotein as a substrate . Relative ERK2 activity duction. Cell 64, 281-302. was determined by autoradiography followed by scanning densitometry.
Chen, Y., O'Toole, T., Shipley, T., Forsyth, J., LaFlamme, S., Yamada, For JNK1 kinase assays, HA-JNK1 was immunoprecipitated with K., Shattil, S., and Ginsberg, M. (1994) . "Inside-out" signal transducantibody 12CA5 as described for the ERK2 kinase assay, resustion inhibited by isolated integrin cytoplasmic domains. J. Biol. pended in kinase buffer containing phosphatase inhibitors, and reChem. 269, 18307-18310. acted with 2 g of a GST fusion protein containing the first 79 Chu, Y., Solski, P.A., Khosravi-Far, R., Der, C.J., and Kelly, K. (1996) . residues of c-Jun as a substrate. After incubation at 30ЊC for 20
The mitogen-activated protein kinase phosphatases PAC1, MKP-1 min, the reaction was stopped with SDS sample buffer. The samples and MKP-2 have unique substrate specificities and reduced activity were then subjected to SDS-polyacrylamide gel electrophoresis on in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271, 10% gels, and the gels were dried and visualized by autoradiog-6497-6501. raphy.
Clark, E.A., and Hynes, R.O. (1996) . Ras activation is necessary for integrin-mediated activation of extracellular signal-regulated kinase Fibronectin Matrix Assembly and Cell Spreading 2 and cytosolic phospholipase A2, but not cytoskeletal organisation. Cells were plated on coverslips and cultured in complete medium.
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